Full Description
This new book explores the latest advances in probiotic research in the prevention and treatment of cancer. The volume first provides an introduction to prebiotics, probiotics, and synbiotics, covering the anticancer properties of probiotic microorganisms, the impact of their metabolites, the potential mechanisms of probiotic chemoprevention, and the feasibility of incorporating probiotics into cancer care strategies. The volume looks at studies that examine the efficacy of probiotics in the treatment and management of such cancers as bladder cancer, colorectal cancer, cervical cancers, lung cancer, brain cancer, and others. It takes an in-depth look at gut microbiota and the role of probiotics as immune boosters and also considers possible toxicology challenges of probiotics as well.
Contents
Introduction to Prebiotics, Probiotics, and Synbiotics 1. Probiotics and Their Potential Effects on Cancer Management 2. Probiotics as a Promising Candidate for the Management of Colorectal Cancer 3. Correlation Between Gut Microbiota and Cancer 4. Importance of Probiotics in Gut Microbiota for the Management of Cancer 5. Role of Prebiotics and Probiotics in Protection against Cervical Cancers 6. Probiotics for the Mitigation of Inflammation-Based Lung Cancer 7. Importance of Synbiotics for the Management of Colorectal Cancers 8. Correlation Between Reactive Oxygen Species (ROS), Inflammation, and Probiotics 9. Probiotics: The Nonpathogenic Microorganisms with a Functional Role in Bladder Cancer Management 10. Immune System Modulation by Probiotics: An Account of Brain Cancers 11. Functional Role of Probiotics in Cancer Prevention and Treatment as Well as Their Role as Immune Boosters 12. Toxicology of Probiotics: Challenges and Future Prospects 13. Impact of SARS-CoV-2 on Cancer Patients and the Role of Probiotics for Management and to Boost the Immune System
